LEQEMBI CLIQSURE
Live / Applied — Fourth extension granted (statement of use) (as of 10 Jan 2026)
What this means for you
Not registered yet, but its 06 Mar 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97825754
- Mark type
- Stylized text
- Filed
- 06 Mar 2023
- Published for opposition
- 12 Dec 2023
- Attorney of record
- Caroline H. Mead
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of Alzheimer's disease and related disorders, cognitive impairment and dementia
Owner
- Eisai R&D Management Co., Ltd., Tokyo, JP
- Eisai R&D Management Co., Ltd., Tokyo, JP
Prosecution history
- 10 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 10 Jan 2026 — SOU EXTENSION 4 GRANTED
- 09 Jan 2026 — SOU EXTENSION 4 FILED
- 09 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 17 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jul 2025 — SOU EXTENSION 3 GRANTED
- 16 Jul 2025 — SOU EXTENSION 3 FILED
- 16 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 23 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jan 2025 — SOU EXTENSION 2 GRANTED
- 22 Jan 2025 — SOU EXTENSION 2 FILED
- 22 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Jul 2024 — SOU EXTENSION 1 GRANTED